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Background/aim: Many autoimmune diseases occur concomitantly with celiac disease (CD). We aimed to determine the frequency of
Sjögren’s syndrome (SS) in CD patients based on SS-specific serology verified by minor labial salivary biopsy.
Materials and methods: Eight-two patients with CD were included in the study. After examination for objective evidence of sicca
complex, all patients were tested for serological presence of rheumatoid factor (RF) and antinuclear antibodies (ANAs) and for ANA
profile. Minor labial salivary biopsy was performed for patients with positive serology and/or clinical signs of SS.
Results: Of the patients included, 24 (29.3%) had dry eye symptoms while 20 (24.4%) had dry mouth symptoms. Dry eye was detected
by Schirmer test in 10 patients (12.2%) and by ocular staining score in only 2 patients (2.4%). All samples were negative for RF while
12 (14.6%) samples were positive for ANAs. Of 82 patients with CD, the diagnosis of SS was established in only one patient (1.2%),
while one patient (1.2%) was diagnosed with morphea and 4 patients (4.9%) were classified as having undifferentiated connective tissue
disease.
Conclusion: The prevalence of SS in CD is low, so there is no need for serologic screening of all patients with CD for SS.
Key words: Celiac disease, Sjögren’s syndrome, antinuclear antibodies, connective tissue disorders

1. Introduction
Sjögren’s syndrome (SS) is a systemic autoimmune disease
characterized by circulating autoantibodies against
intracellular autoantigens and destruction of the exocrine
glands due to lymphocytic infiltration (1,2). In addition to
the exocrine glands, many other organs such as the lungs,
kidneys, peripheral nervous system, and joints can be
involved in patients with SS. Gastrointestinal symptoms
such as dysphagia due to diminished saliva and esophageal
dysmotility, epigastric pain, and chronic atrophic gastritis
can also be seen in SS (3).
Celiac disease (CD) is an autoimmune enteropathy
induced by dietary glutens such as gliadin found in wheat.
This enteropathy is characterized by a wide spectrum of
clinical symptoms including chronic diarrhea, weight loss,
abdominal distension, and less commonly extraintestinal
manifestations such as anemia, edema, recurrent oral
aphthae, and arthritis (4).
* Correspondence: fundaerb@yahoo.com
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Many autoimmune diseases such as dermatitis
herpetiformis, type 1 diabetes, autoimmune thyroiditis,
primary biliary cirrhosis, autoimmune hepatitis, primary
sclerosing cholangitis, and Addison’s disease have been
previously reported in patients with CD (5). The association
of CD with SS was first described by Pittman and Holub
in 1965 (6). Since then, a few reports have confirmed this
association and have suggested the frequency of SS in CD
to be as high as 15% (7). The association between SS and
CD can be at least partly explained by a similar genetic
involvement, namely the DQ2 heterodimer coded by the
DQA1*0501 and DQB1*0201 alleles (8,9).
In this study, we aimed to determine the frequency of
SS in CD patients based on SS-specific serology verified
by minor salivary gland biopsy. We think that this study
can provide additional information about the need for
investigation of SS in patients with CD.
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2. Materials and methods
2.1. Patients
The study cohort included patients with CD who were
followed at the Department of Gastroenterology of
Antalya Training and Research Hospital between 2010
and 2014. The diagnosis of CD was made according
to positive celiac autoantibodies (antiendomysial
antibodies and/or antitissue transglutaminase antibodies)
and pathognomonic changes in the histopathological
examination of the small intestine. The diagnosis of
Sjögren’s syndrome was made according to the 2012
American College of Rheumatology (ACR) classification
criteria for SS (10). The study protocol was approved by
the Ethics Committee of Antalya Training and Research
Hospital (2014 - 36/4). All patients gave written informed
consent before participation.
All patients were questioned about other systemic
diseases and drugs that can affect the salivary and lacrimal
glands. The exclusion criteria were history of hepatitis
C, human immunodeficiency virus, graft-versus-host
disease, sarcoidosis, active tuberculosis, amyloidosis,
and radiotherapy to the head and neck area. After a
systemic examination in the rheumatology department,
all patients underwent an examination for dry eye. In
all patients, Schirmer test, tear film tear break-up time
(TBUT), corneal epithelial staining using fluorescein, and
conjunctival epithelial staining using lissamine green were
performed. The eyes were graded separately and the ocular
staining score (OSS) was recorded. Schirmer score of <5
mm (without anesthesia), TBUT of ≤10 s, and OSS of ≥3
were considered as abnormal and signs of dry eye.
2.2. Laboratory tests
A volume of 10 mL of venous blood was taken from each
patient. After centrifugation, all serum samples were
maintained at –80 °C until use. Antinuclear antibodies
(ANAs) were detected by indirect immunofluorescence
on HEp-2 cells (Euroimmun, Lubeck, Germany) at a
screening dilution of 1:100 for every patient and control.
Preparations stained according to the manufacturer’s
recommendations were evaluated by fluorescence
microscope (EurostarII, Euroimmun) with 40× lenses.
Fluorescent acuity was determined semiquantitatively
based on negative control (-) and positive control (+4)
ranging from +1 to +5. Besides nuclear patterns reported as
granular, homogeneous, cytoplasmic membrane, nuclear
speckled and DFS70, centromere, and nucleolar patterns
were also identified. A subgroup of patients and controls
was further tested at dilutions of 1:320 and 1:1000.
The ANA profile test was performed using the ANA
profile 3 kit (Euroline, Euroimmun) at 1:100 dilution in
accordance with the manufacturer’s recommendations.
This kit provides a quantitative in vitro assay for human
autoantibodies of the IgG class to 14 different antigens:

uridine 1-low-molecular-weight ribonuclear protein
(nRNP), Smith antigen (Sm), soluble substance A (SSA native and Ro 52), soluble substance B (SS-B), DNA
topoisomerase I (Scl-70), cytoplasmic histidyl-tRNA
synthetase (Jo-1), centromeres (CENP B), proliferating
cell nuclear antigen (PCNA), double stranded DNA
(dsDNA), nucleosomes, histones, ribosomal P-protein
(RibPP), and pyruvate dehydrogenase complex including
antimitochondrial M2 antigens (AMA-M2) in serum
or plasma. Rheumatoid factor (RF) was detected with
a commercially available kit (N Latex RF kit, Siemens
Diagnostics, Marburg, Germany).
When clinically indicated, minor salivary gland
biopsy was taken just after receiving the patient’s
permission. Biopsy samples were immediately fixed in
10% formaldehyde and embedded in paraffin and then
4-µm-thick sections were obtained from paraffin blocks
and stained with hematoxylin-eosin for conventional
histopathological examination. The focus score was defined
as the group of inflammatory cell aggregates containing at
least 50 mononuclear cells per 4 mm2 of tissue area (11).
2.3. Statistical analysis
The data were analyzed with descriptive statistics. Data are
presented as mean ± SD or percentage. Statistical analyses
were performed using SPSS 18.
3. Results
Overall 82 patients (60 women and 22 men) were included
in the study. All the patients were on gluten-free diets for at
least 1 year. Table 1 presents epidemiological and clinical
features of the study population.
Table 1. Epidemiological and clinical features of the study
population (n = 82).
Features
Female/male

60/22

Age, mean years (range)

40.65 (20–62)

Dry mouth symptoms, n (%)

20 (24.4)

Dry eye symptoms, n (%)

24 (29.3)

Aphthous stomatitis, n (%)

9 (11)

Raynaud’s phenomenon, n (%)

1 (1.2)

Co-morbid diseases, n (%)
Autoimmune thyroiditis

4 (4.9)

Diabetes mellitus

6 (7.3)

Hypertension

3 (3.6)

Depression

8 (8.9)
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4 patients diagnosed with UCTD, there was symmetrical
polyarthralgia and prolonged morning stiffness in 3
patients and erythematous skin lesion in one patient.
Of these, no patient fulfilled the criteria for rheumatoid
disorder. Table 2 presents the clinical details of these
patients.

Twenty-four patients with CD (29.3%) had dry eye
symptoms but 9 patients (11%) were using systemic
medications that could contribute to their dry eye
symptoms. Dry eye was detected in 10 patients (12.2%) by
Schirmer test, in 22 patients (26.8%) by TBUT, and in only
2 patients (2.4%) by OSS.
All samples were negative for RF. Twelve patients
(14.6%), who were in serological remission for CD, were
positive for ANAs; however, of these, 6 patients were
asymptomatic. They were all negative for SS-A, SS-B, and
the other autoantibodies analyzed. Of three patients with
negative ANAs, 2 had anti-Ro52 and one had anti-SSA, all
of whom had no symptoms or signs. There was history of
Hashimoto thyroiditis in 2 of 6 patients.
There were 5 patients with suspicious SS. The minor
salivary gland biopsies revealed that only one patient had
a focus score of ≥1, while the remaining 4 patients had
focus scores of <1. Of the 82 CD patients, a diagnosis
of SS was established in only one patient (1.2%). In
addition, one patient (1.2%) was diagnosed with
morphea while 4 patients (4.9%) were classified as having
undifferentiated connective tissue disease (UCTD). Of the

4. Discussion
Currently, it is known that CD may be associated with
other autoimmune diseases. Several studies have revealed
a high prevalence of CD among patients with SS. Iltanen et
al. found that 5 patients (14.7%) had CD among 34 patients
with primary SS (7). This high prevalence was confirmed
by Szodoray et al., who observed a CD prevalence of
4.5% in a population of 111 patients with SS, whereas the
prevalence of CD is estimated to be 0.45% in the general
population (12).
In 1994, Collin et al. showed that patients with CD
have an increased prevalence of autoimmune diseases,
especially insulin-dependent diabetes and SS (13). Based
on California criteria, SS was diagnosed in 3.3% of celiac
patients (13). We found the prevalence of SS to be 1.2%,

Table 2. Clinical characteristics and laboratory findings of patients with CTD.
Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Diagnosis

SS

Morphea

UCTD

UCTD

UCTD

UCTD

Sex

Female

Female

Female

Female

Female

Male

Age

50

57

51

52

55

48

Dry eye symptoms

+

-

+

+

-

-

Dry mouth symptoms

+

-

+

+

+

+

Arthralgia

+

-

+

+

+

-

Cutaneous lesions/sclerosis

-

-

-

-

-

+/-

RP

-

-

-

-

-

-

OSS

8;8

0;0

2;2

2;2

1;1

0;0

ESR

89

83

48

14

21

12

RF

-

-

-

-

-

-

ANA

Speckled

Homogeneous

Centromere

Speckled

Speckled

Homogeneous

ANA titer

1/100

1/320

1/100

1/100

1/320

1/1000

ENAA

SSA/SSB

-

ACA

SSA

SSA

-

MSGB(FS)

One

-

Zero

Zero

Zero

Zero

Capillaroscopy

-

Normal

Normal

-

-

-

CTD: Connective tissue disease, SS: Sjögren’s syndrome, UCTD: undifferentiated connective tissue diseases, RP: Raynaud’s
phenomenon, OSS: ocular staining score, ESR: erythrocyte sedimentation rate, RF: rheumatoid factor, ANA: antinuclear antibody,
ENAA: extractable nuclear antigen antibodies, ACA: anticentromere antibody, MSGB: minor salivary gland biopsy, FS: focus score.
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which is similar to the rate of the general population. The
incidence and the prevalence of SS vary widely depending
on the specific classification criteria, study design, and
population examined. In our study, we used the ACR
classification criteria for SS diagnosis. The reason for this
difference in prevalence rates may be due to different
classification criteria used. Iqbal et al. reported that the SS
prevalence was 0.8%, but that was a survey-based study
and the criteria used were not specified (14).
Arthritis involving both the peripheral and axial joints
has been reported in as many as 26% of patients presenting
with CD (15). More recent reports suggest a lower
proportion of subjects with CD presenting with arthritis
(1%) (16). In our study, 13% of CD patients had symptoms
of arthralgia while no arthritis was seen in these patients.
The arthritis in CD is acute and nonerosive and generally
resolves with the institution of a gluten-free diet. In our
study, all patients were on a gluten-free diet, which may
explain lack of arthritis. Furthermore, the differences in the
arthritis prevalence may depend on the diet compliance of
patients screened for arthritis.
Dental enamel defects in permanent and mucosal
inflammatory lesions such as recurrent aphthous ulcers and
angular cheilitis are common in CD (17–19). Moreover,
dental caries due to the decreased salivary flow can be seen
frequently in SS. Thus, patients who have concomitant CD
and SS are at risk of mucosal and dental abnormalities. In
our study, the frequency of dry mouth was 24.4% in the
individuals with CD, which is lower than the rate reported
(40%) in the study of Patinen et al. (20). They found that
the median salivary gland focus score of patients with
CD was 2.1 (1.0–3.1) and they reported that patients with
CD can develop sialadenitis without accompanying SS
(20). However, in our study, except for the SS patient, the
salivary gland focus scores obtained from the 4 patients
diagnosed with UCTD were zero. Thus, we disagree with
the opinion that celiac patients without SS could have
subclinical autoimmune focal sialadenitis. However, to
be able to comment better on this subject, more extensive
studies should be done.
Mollazadegan et al. found a moderately increased risk
of uveitis and cataracts in patients with biopsy-verified CD

(21,22). However, in the literature, there are no data about
dry eye syndrome in CD patients. While dry eye symptoms
were found in 24 patients, only 9 (10.9%) patients had
clinically significant dry eye that was not due to a systemic
disease or drug. In this study, dry eye was detected at a
high rate in CD patients, but it is unclear whether there is
a causal relationship between these two situations.
In the literature, a high rate of ANA positivity has
been reported in individuals with CD. Utiyama et al.
detected ANA positivity to be significantly high in CD
with a frequency of 8.9% (23). In the study by Caglar et
al., ANA frequency in the patients with CD was 12.9%, but
there was no significant difference between the patients
and healthy controls (13.8%) (24). In our study, the ANA
test was positive in 12 (14.6%) patients. Of these, 8 (9.8%)
had another autoimmune disease, including connective
tissue disease in 6 patients and Hashimoto thyroiditis in
2 patients. The ANA rate in our study was similar to those
previously detected. Previously, the SS-A/SS-B antibody
was detected in 6.4% (2/31) of patients with CD who had
systemic lupus erythematosus and SS (24). We found SS-A
in one patient and Ro52 in 2 patients without any other
autoimmune disease. These patients were on a gluten-free
diet when examined for autoantibody frequency and no
analysis was done before switching to a gluten-free diet. It
is known that all celiac-related antibodies decline after a
period of a gluten-free diet. Similarly, gluten-free diets can
lead to negativity in the ANA test.
In our cohort study, the prevalence of SS in CD was
approximately similar to the value reported in the general
population. However, our study has some limitations. We
used a cross-sectional approach and evaluated only patients
who were on a gluten-free diet. The effect of a gluten-free
diet on the development of autoimmune disease and ANA
positivity is still under debate. Therefore, examination of
SS and ANA prevalence might be more accurate before the
beginning of a gluten-free diet.
In conclusion, contrary to the previously published
studies, despite the high frequency of positive ANAs, we
found the prevalence of SS low in CD. There is no need for
routine screening of SS in patients with CD.
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